BR0207254A - Composto, composição farmacêutica, uso de pelo menos um composto, e, método para tratar distúrbios associados com um sistema imune perturbado - Google Patents
Composto, composição farmacêutica, uso de pelo menos um composto, e, método para tratar distúrbios associados com um sistema imune perturbadoInfo
- Publication number
- BR0207254A BR0207254A BR0207254-8A BR0207254A BR0207254A BR 0207254 A BR0207254 A BR 0207254A BR 0207254 A BR0207254 A BR 0207254A BR 0207254 A BR0207254 A BR 0207254A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- immune system
- pharmaceutical composition
- disorders associated
- treating disorders
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 210000000987 immune system Anatomy 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 230000004064 dysfunction Effects 0.000 abstract 1
- 150000002460 imidazoles Chemical class 0.000 abstract 1
- 230000002519 immonomodulatory effect Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Transplantation (AREA)
Abstract
"COMPOSTO, COMPOSIçãO FARMACêUTICA, USO DE PELO MENOS UM COMPOSTO, E, MéTODO PARA TRATAR DISTúRBIOS ASSOCIADOS COM UM SISTEMA IMUNE PERTURBADO". A invenção diz respeito a derivados de imidazol 2-tio-substituídos da fórmula I em que os grupos R~ 1~, R~ 2~, R~ 3~ e R~ 4~ são definidos de acordo com a descrição. Os compostos inventivos têm uma ação imunomoduladora e/ou uma ação inibidora da liberação de citocina e são, portanto, adequados para tratar doenças, que estão relacionadas com a disfunção do sistema imune.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10107683A DE10107683A1 (de) | 2001-02-19 | 2001-02-19 | 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie |
PCT/EP2002/001746 WO2002066458A2 (de) | 2001-02-19 | 2002-02-19 | 2-thio-substituierte imidazolderivate und ihre verwendung in der pharmazie |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0207254A true BR0207254A (pt) | 2004-02-10 |
Family
ID=7674545
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0207254-8A BR0207254A (pt) | 2001-02-19 | 2002-02-19 | Composto, composição farmacêutica, uso de pelo menos um composto, e, método para tratar distúrbios associados com um sistema imune perturbado |
Country Status (23)
Country | Link |
---|---|
US (1) | US7253191B2 (pt) |
EP (1) | EP1362045B1 (pt) |
JP (1) | JP2004521913A (pt) |
KR (1) | KR100642231B1 (pt) |
CN (1) | CN1291984C (pt) |
AT (1) | ATE282605T1 (pt) |
AU (1) | AU2002247726C1 (pt) |
BR (1) | BR0207254A (pt) |
CA (1) | CA2453078A1 (pt) |
CZ (1) | CZ20032224A3 (pt) |
DE (2) | DE10107683A1 (pt) |
DK (1) | DK1362045T3 (pt) |
ES (1) | ES2233808T3 (pt) |
HK (1) | HK1056725A1 (pt) |
HU (1) | HUP0303155A3 (pt) |
IL (1) | IL157050A0 (pt) |
IS (1) | IS6914A (pt) |
MX (1) | MXPA03007380A (pt) |
PL (1) | PL367397A1 (pt) |
PT (1) | PT1362045E (pt) |
RU (1) | RU2284326C2 (pt) |
SK (1) | SK10242003A3 (pt) |
WO (1) | WO2002066458A2 (pt) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10107683A1 (de) | 2001-02-19 | 2002-08-29 | Merckle Gmbh Chem Pharm Fabrik | 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie |
DE10222103A1 (de) * | 2002-05-17 | 2003-11-27 | Merckle Gmbh Chem Pharm Fabrik | 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie |
DE10238045A1 (de) * | 2002-08-20 | 2004-03-04 | Merckle Gmbh Chem.-Pharm. Fabrik | 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie |
DE10256881A1 (de) * | 2002-12-05 | 2004-06-24 | Beiersdorf Ag | Neue topische Verwendung von Bis-Arylimidazo[1,2-a]thiolanderivaten |
EP1756089B1 (en) | 2004-05-26 | 2008-10-22 | Janssen Pharmaceutica N.V. | Mercaptoimidazoles as ccr2 receptor antagonists |
WO2005118578A1 (en) | 2004-05-26 | 2005-12-15 | Janssen Pharmaceutica N.V. | Mercaptoimidazoles as ccr2 receptor antagonists |
CA2573066A1 (en) * | 2004-08-11 | 2006-02-16 | Janssen Pharmaceutica N.V. | Mercaptoimidazoles as ccr2 receptor antagonists |
EP1853581B1 (en) * | 2005-02-28 | 2010-06-02 | Merckle Gmbh | 2-sulfinyl- and 2-sulfonyl-substituted imidazole derivatives and their use as cytokine inhibitors |
EP1894925A1 (en) * | 2006-08-24 | 2008-03-05 | Merckle Gmbh | Imidazole compounds having an antiinflammatory effect |
WO2008085008A1 (en) * | 2007-01-11 | 2008-07-17 | Mogam Biotechnology Research Institute | T-cell inhibiting compounds and their use for the treatment of t-cell-mediated diseases |
US8143294B2 (en) | 2007-12-31 | 2012-03-27 | Michael Burnet | 2-sulfanyl-substituted imidazole derivatives and their use as cytokine inhibitors |
CN102249992A (zh) * | 2011-07-05 | 2011-11-23 | 广东工业大学 | 一种制备2-氨基异烟酸的方法 |
DE102013102069A1 (de) | 2013-03-01 | 2014-09-04 | Fsp Fluid Systems Partners Holding Ag | Proportional-Wegeventil sowie hydraulische Schaltung und hydropneumatisches Federungssystem mit einem derartigen Ventil |
US20190060286A1 (en) | 2016-02-29 | 2019-02-28 | University Of Florida Research Foundation, Incorpo | Chemotherapeutic Methods |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL6614808A (pt) * | 1965-10-21 | 1967-04-24 | ||
US4190666A (en) * | 1975-08-11 | 1980-02-26 | E. I. Du Pont De Nemours And Company | Anti-inflammatory 4,5-diarly-2-(substituted-thio)imidazoles and their corresponding sulfoxides and sulfones |
DK16778A (da) | 1977-02-09 | 1978-08-10 | Du Pont | Imidazolderivater deres anvendelser og fremstilling |
DE2963572D1 (en) * | 1978-04-11 | 1982-10-21 | Ciba Geigy Ag | Mercapto-imidazole derivatives, their preparation, mercapto-imidazole derivatives for the treatment of inflammatory diseases and their pharmaceutical compositions |
DE2823197A1 (de) | 1978-05-24 | 1979-11-29 | Schering Ag | Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
DE3025484A1 (de) * | 1980-07-03 | 1982-02-04 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue imidazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
DE3141063A1 (de) * | 1981-10-13 | 1983-04-28 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue imidazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
DE3504678A1 (de) * | 1985-02-12 | 1986-08-14 | A. Nattermann & Cie GmbH, 5000 Köln | Neue imidazolyl-oxyalkansaeuren und -thioalkansaeuren, ihre derivate und verfahren zu ihrer herstellung |
US4686231A (en) | 1985-12-12 | 1987-08-11 | Smithkline Beckman Corporation | Inhibition of 5-lipoxygenase products |
JPS6440467A (en) | 1987-08-04 | 1989-02-10 | Hisamitsu Pharmaceutical Co | Novel substituted diphenylimidazole derivative |
FR2626691B1 (fr) | 1988-02-02 | 1990-05-25 | France Etat | Multiplieur numerique generalise et filtre numerique mettant en oeuvre ce multiplieur |
EP0510036B1 (en) | 1990-01-12 | 1995-04-19 | Aventis Pharma S.A. | 2-substituted 4,5-diphenyl-imidazoles |
MX9300141A (es) | 1992-01-13 | 1994-07-29 | Smithkline Beecham Corp | Compuestos de imidazol novedosos, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen. |
US5364875A (en) * | 1992-05-11 | 1994-11-15 | The Du Pont Merck Pharmaceutical Company | Imidazoles linked to bicyclic heterocyclic groups for the treatment of atherosclerosis |
US5474995A (en) | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
WO1995003297A1 (en) | 1993-07-21 | 1995-02-02 | Smithkline Beecham Corporation | Imidazoles for treating cytokine mediated disease |
US5620999A (en) | 1994-07-28 | 1997-04-15 | Weier; Richard M. | Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation |
JP2002515915A (ja) | 1997-06-30 | 2002-05-28 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 炎症性疾患の治療で有用な2−置換イミダゾール類 |
DE19842833B4 (de) * | 1998-09-18 | 2005-04-14 | Merckle Gmbh | 2-Arylalkylthio-imidazole, 2-Arylalkenylthio-imidazole und 2-Arylalkinylthio-imidazole als Entzündungs-Hemmstoffe und Hemmstoffe der Cytokin-Freisetzung |
DE10107683A1 (de) | 2001-02-19 | 2002-08-29 | Merckle Gmbh Chem Pharm Fabrik | 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie |
-
2001
- 2001-02-19 DE DE10107683A patent/DE10107683A1/de not_active Withdrawn
-
2002
- 2002-02-19 CN CNB028051548A patent/CN1291984C/zh not_active Expired - Fee Related
- 2002-02-19 US US10/467,064 patent/US7253191B2/en not_active Expired - Fee Related
- 2002-02-19 DK DK02716791T patent/DK1362045T3/da active
- 2002-02-19 EP EP02716791A patent/EP1362045B1/de not_active Expired - Lifetime
- 2002-02-19 AU AU2002247726A patent/AU2002247726C1/en not_active Ceased
- 2002-02-19 JP JP2002565973A patent/JP2004521913A/ja active Pending
- 2002-02-19 KR KR1020037010839A patent/KR100642231B1/ko not_active IP Right Cessation
- 2002-02-19 RU RU2003128068/04A patent/RU2284326C2/ru not_active IP Right Cessation
- 2002-02-19 CZ CZ20032224A patent/CZ20032224A3/cs unknown
- 2002-02-19 MX MXPA03007380A patent/MXPA03007380A/es active IP Right Grant
- 2002-02-19 IL IL15705002A patent/IL157050A0/xx unknown
- 2002-02-19 WO PCT/EP2002/001746 patent/WO2002066458A2/de active IP Right Grant
- 2002-02-19 DE DE50201565T patent/DE50201565D1/de not_active Expired - Lifetime
- 2002-02-19 ES ES02716791T patent/ES2233808T3/es not_active Expired - Lifetime
- 2002-02-19 PT PT02716791T patent/PT1362045E/pt unknown
- 2002-02-19 PL PL02367397A patent/PL367397A1/xx not_active Application Discontinuation
- 2002-02-19 CA CA002453078A patent/CA2453078A1/en not_active Abandoned
- 2002-02-19 SK SK1024-2003A patent/SK10242003A3/sk not_active Application Discontinuation
- 2002-02-19 AT AT02716791T patent/ATE282605T1/de not_active IP Right Cessation
- 2002-02-19 HU HU0303155A patent/HUP0303155A3/hu unknown
- 2002-02-19 BR BR0207254-8A patent/BR0207254A/pt not_active IP Right Cessation
-
2003
- 2003-08-15 IS IS6914A patent/IS6914A/is unknown
- 2003-12-11 HK HK03109068A patent/HK1056725A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2002247726B2 (en) | 2006-01-19 |
US20040116416A1 (en) | 2004-06-17 |
US7253191B2 (en) | 2007-08-07 |
DE10107683A1 (de) | 2002-08-29 |
PL367397A1 (en) | 2005-02-21 |
JP2004521913A (ja) | 2004-07-22 |
HUP0303155A2 (hu) | 2003-12-29 |
PT1362045E (pt) | 2005-04-29 |
CN1511149A (zh) | 2004-07-07 |
WO2002066458A3 (de) | 2002-12-12 |
RU2284326C2 (ru) | 2006-09-27 |
MXPA03007380A (es) | 2004-03-16 |
WO2002066458A2 (de) | 2002-08-29 |
KR20030082940A (ko) | 2003-10-23 |
AU2002247726C1 (en) | 2006-08-17 |
RU2003128068A (ru) | 2005-01-27 |
CZ20032224A3 (en) | 2004-06-16 |
ES2233808T3 (es) | 2005-06-16 |
ATE282605T1 (de) | 2004-12-15 |
DK1362045T3 (da) | 2005-03-29 |
HUP0303155A3 (en) | 2007-08-28 |
IL157050A0 (en) | 2004-02-08 |
IS6914A (is) | 2003-08-15 |
DE50201565D1 (de) | 2004-12-23 |
CA2453078A1 (en) | 2002-08-29 |
EP1362045B1 (de) | 2004-11-17 |
SK10242003A3 (sk) | 2004-03-02 |
HK1056725A1 (en) | 2004-02-27 |
EP1362045A2 (de) | 2003-11-19 |
KR100642231B1 (ko) | 2006-11-02 |
CN1291984C (zh) | 2006-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0416752A (pt) | composição farmacêutica, uso de um ou mais compostos, método para a prevenção ou tratamento de distúrbios, compostos, e, processo para a preparação de uma composição farmacêutica | |
BR0207254A (pt) | Composto, composição farmacêutica, uso de pelo menos um composto, e, método para tratar distúrbios associados com um sistema imune perturbado | |
BRPI0307351B8 (pt) | composto, composição farmacêutica, uso de um composto, e, processo para preparar um composto | |
DE69417012D1 (de) | Cyclobutan-derivate als inhibitoren der squalen-synthetase und der protein-farnesyltransferase | |
BR0206968A (pt) | Ciclobuteno-1,2-dionas 3,4-dissubstituìdas como antagonistas receptores de quimiocina cxc | |
NO944643L (no) | Protein-kinase-C-hemmere | |
BR0310099A (pt) | método para tratar dislipidemia ou uma doença associada com a dislipidemia | |
BR9800228A (pt) | Compostos de peridilfurano e piridiltiofeno | |
BRPI0414514A (pt) | uso de um composto, composto, e, composições farmacêuticas | |
BR0313265A (pt) | Compostos e respectivos processos de preparação, uso e formulações farmacêuticas e métodos de prevenção e/ou tratamento de distúrbios mediados por receptor mglur5 e de inbição da ativação de receptores mglu r5. | |
BR0312464A (pt) | Inibidores de tirosina quinases | |
BR0212986A (pt) | Derivados de imizadol-4-carboxamida, preparação e uso dos mesmos para tratamento de obesidade | |
YU60996A (sh) | Inhibitor protein kinaze c, njegove faramceutske formulacije i postupak za dobijanje | |
BR0312020A (pt) | Método de tratamento de distúrbios, compostos, composições farmacêuticas, e, uso de um composto | |
DE69920757D1 (de) | Immunsuppressive wirkungen von pteridinderivaten | |
ES2171723T3 (es) | 3,4-diaril-2-hidroxi-2,5-dihidrofuranos como profarmacos de inhibidores de cox-2. | |
DE69634961D1 (de) | Neue zyklische depsipeptid pf1022 derivate | |
BR0315662A (pt) | Derivados de 1-(4-benzil-piperazin-1-il)-3-fenil-propenona | |
ATE368040T1 (de) | Substituierte tetrazyklische pyprolochinolonderivate als phosphodiesterase- inhibitoren | |
ATE251638T1 (de) | 2-substituierte nukleosid- und oligonukleotid- derivate | |
BR0111897A (pt) | Composto, método para tratar um indivìduo afligido por alguns distúrbios dos sistemas nervosos periférico e central, composição farmacêutica, e, uso de um composto | |
BR0313277A (pt) | Composto, agente farmacêutico, uso de pelo menos um composto, e, método para tratar as doenças associadas com um distúrbio do sistema imune | |
NO20020914L (no) | Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav | |
IT1258788B (it) | Derivati solforati di acidi biliari | |
BR0201312A (pt) | Compostos de pirimidin-4-ona, processo para sua preparação e composições farmacêuticas contendo os referidos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE(S). |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2103 DE 26/04/2011. |